Kadmon Holdings Inc (NASDAQ:KDMN) – Analysts at Jefferies Group lifted their FY2016 earnings per share (EPS) estimates for Kadmon Holdings in a research report issued on Wednesday. Jefferies Group analyst B. Amin now anticipates that the brokerage will post earnings of ($9.66) per share for the year, up from their previous estimate of ($9.82). Jefferies Group currently has a “Buy” rating and a $10.00 target price on the stock. Jefferies Group also issued estimates for Kadmon Holdings’ Q4 2016 earnings at ($0.57) EPS, FY2017 earnings at ($2.05) EPS, FY2018 earnings at ($1.81) EPS, FY2019 earnings at ($1.55) EPS and FY2020 earnings at ($1.27) EPS.

Kadmon Holdings (NASDAQ:KDMN) last announced its earnings results on Wednesday, November 9th. The company reported ($4.23) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.40) by $3.83. The business earned $5.70 million during the quarter, compared to the consensus estimate of $3.90 million. The business’s revenue for the quarter was down 49.6% on a year-over-year basis.

KDMN has been the topic of a number of other research reports. Citigroup Inc. started coverage on shares of Kadmon Holdings in a research report on Monday, August 22nd. They set a “neutral” rating and a $12.00 target price on the stock. HC Wainwright started coverage on shares of Kadmon Holdings in a research report on Monday, August 22nd. They set a “buy” rating and a $25.00 target price on the stock. WBB Securities started coverage on shares of Kadmon Holdings in a research report on Monday, August 1st. They set a “sell” rating and a $7.50 target price on the stock. Finally, JMP Securities started coverage on shares of Kadmon Holdings in a research report on Monday, August 22nd. They set an “outperform” rating and a $16.00 target price on the stock. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $14.10.

Shares of Kadmon Holdings (NASDAQ:KDMN) opened at 6.66 on Monday. The stock’s market cap is $300.22 million. Kadmon Holdings has a 12 month low of $4.44 and a 12 month high of $10.48. The firm has a 50-day moving average price of $6.24 and a 200-day moving average price of $7.84.

In related news, major shareholder Daniel S. Loeb purchased 19,611 shares of the business’s stock in a transaction on Wednesday, September 14th. The shares were bought at an average price of $7.79 per share, with a total value of $152,769.69. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Daniel S. Loeb purchased 32,916 shares of the business’s stock in a transaction on Friday, August 26th. The shares were bought at an average cost of $9.98 per share, for a total transaction of $328,501.68. The disclosure for this purchase can be found here.

Institutional investors have recently bought and sold shares of the company. BlackRock Institutional Trust Company N.A. bought a new position in Kadmon Holdings during the third quarter worth $129,000. California State Teachers Retirement System bought a new position in Kadmon Holdings during the third quarter worth $126,000. Beach Point Capital Management LP bought a new position in Kadmon Holdings during the third quarter worth $1,480,000. Morgan Stanley bought a new position in Kadmon Holdings during the third quarter worth $2,180,000. Finally, KCG Holdings Inc. bought a new position in Kadmon Holdings during the third quarter worth $102,000.

About Kadmon Holdings

Kadmon Holdings, Inc, formerly Kadmon Holdings, LLC, is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of small molecules and biologics. The Company is developing product candidates within autoimmune and fibrotic diseases, oncology and genetic diseases.

5 Day Chart for NASDAQ:KDMN

Receive News & Stock Ratings for Kadmon Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kadmon Holdings Inc and related stocks with our FREE daily email newsletter.